Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

322 ARTÍCULOS , VIENDO DEL 286 AL 300

Targeting Abeta and tau in Alzheimer's disease, an early interim report

Golde TE, Petrucelli L, Lewis J.

Exp Neurol. 2010 Jun;223(2):252-66. doi: 10.1016/j.expneurol.2009.07.035. Epub 2009 Aug 27.

Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia

Darreh-Shori T, Jelic V.

Expert Opin Drug Saf. 2010 Jan;9(1):167-76. doi: 10.1517/14740330903439717.

Targeted hydrolysis of Beta-amyloid with engineered antibody fragment

Kasturirangan S, Sierks M.

Curr Alzheimer Res. 2010 May;7(3):214-22. doi: 10.2174/156720510791050876.

New therapeutic strategy for Parkinson's and Alzheimer's disease

Esposito E, Cuzzocrea S.

Curr Med Chem. 2010;17(25):2764-74. doi: 10.2174/092986710791859324.

[Development of gene therapy in major brain diseases]

Fan L, Jiang XG.

Yao Xue Xue Bao. 2010 Sep;45(9):1095-102.

Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea

Sabbagh MN, Shill HA.

Curr Opin Investig Drugs. 2010 Jan;11(1):80-91.

Developing effective educational approaches for Liaison Old Age Psychiatry teams: a literature review of the learning needs of hospital staff in relation to managing the confused older patient

Teodorczuk A, Welfare M, Corbett S, Mukaetova-Ladinska E.

Int Psychogeriatr. 2010 Sep;22(6):874-85. doi: 10.1017/S1041610209991475. Epub 2009 Dec 15.

The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects

Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C.

Trends Genet. 2010 Feb;26(2):84-93. doi: 10.1016/j.tig.2009.12.004. Epub 2010 Jan 18.

Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations

Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R.

J Alzheimers Dis. 2010;20(1):301-11. doi: 10.3233/JAD-2010-1362.

Vascular and psychosocial factors in Alzheimer's disease: epidemiological evidence toward intervention

Qiu C, Xu W, Fratiglioni L.

J Alzheimers Dis. 2010;20(3):689-97. doi: 10.3233/JAD-2010-091663.

Modifiable lifestyle risk factors for Alzheimer's disease

Flicker L.

J Alzheimers Dis. 2010;20(3):803-11. doi: 10.3233/JAD-2010-091624.

[How Can we provide better services for demented nursing home residents suffering from apathy?]

Treusch Y, Jerosch D, Majic T, Heinz A, Gutzmann H, Rapp MA.

Psychiatr Prax. 2010 Mar;37(2):84-8. doi: 10.1055/s-0029-1223472. Epub 2010 Feb 24.

Aluminum in the diet and Alzheimer's disease: from current epidemiology to possible disease-modifying treatment

Frisardi V, Solfrizzi V, Capurso C, Kehoe PG, Imbimbo BP, Santamato A, Dellegrazie F, Seripa D, Pilotto A, Capurso A, Panza F.

J Alzheimers Dis. 2010;20(1):17-30. doi: 10.3233/JAD-2009-1340.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias